PMID- 31061878 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200930 IS - 2364-3722 (Print) IS - 2196-9736 (Electronic) IS - 2196-9736 (Linking) VI - 7 IP - 5 DP - 2019 May TI - Endoscopic submucosal dissection in management of colorectal tumors near or involving a diverticulum: a retrospective case series. PG - E664-E671 LID - 10.1055/a-0848-8048 [doi] AB - Background and study aims Surgery is the standard treatment for colon tumors associated with diverticulum. U se of endoscopic submucosal dissection (ESD) to treat such tumors is controversial. The aim of this study was to assess the safety and feasibility of ESD in treating superficial colorectal tumors situated near or involving diverticulum. Patients and methods Consecutive patients from two referral centers who had colorectal tumors near or involving diverticulum treated by ESD were retrospectively studied. Clinicopathological characteristics and clinical outcomes were analyzed. Results Of the 12 patients studied, six had tumors near diverticulum and six had tumors involving diverticulum. The overall en-bloc R0 resection rate, median tumor size and procedure time were 67 %, 26.5 mm (range, 15 - 80 mm) and 110 minutes (range, 50 - 220 minutes), respectively. For tumors near diverticulum group, the en-bloc R0 resection rate was 100 % and no adverse events (AEs) or residual/recurrent tumors were observed. In contrast, for intradiverticular tumors group, the en-bloc R0 resection rate was low at 33 %, and one AE (perforation) was observed. The diverticula were >/= 6 mm in diameter in the patients with incomplete resection. However, all but one diverticulum was unrecognized before ESD. Two residual tumors were detected at the 12-month surveillance and one required surgery. Conclusions This case series indicates that ESD is safe and feasible for treating colorectal tumors near a diverticulum and might be feasible for tumors involving a diverticulum smaller than 6 mm. Selection for smaller diverticulum size may contribute to higher en-bloc R0 resection rates. FAU - Jimenez-Garcia, Victoria Alejandra AU - Jimenez-Garcia VA AD - National Cancer Center Hospital, Endoscopy Division, Tokyo, Japan. FAU - Yamada, Masayoshi AU - Yamada M AD - National Cancer Center Hospital, Endoscopy Division, Tokyo, Japan. FAU - Ikematsu, Hiroaki AU - Ikematsu H AD - National Cancer Center Hospital East, Division of Endoscopy and Gastrointestinal Oncology, Kashiwa, Japan. FAU - Takamaru, Hiroyuki AU - Takamaru H AD - National Cancer Center Hospital, Endoscopy Division, Tokyo, Japan. FAU - Abe, Seiichiro AU - Abe S AD - National Cancer Center Hospital, Endoscopy Division, Tokyo, Japan. FAU - Sakamoto, Taku AU - Sakamoto T AD - National Cancer Center Hospital, Endoscopy Division, Tokyo, Japan. FAU - Nakajima, Takeshi AU - Nakajima T AD - National Cancer Center Hospital, Endoscopy Division, Tokyo, Japan. FAU - Matsuda, Takahisa AU - Matsuda T AD - National Cancer Center Hospital, Endoscopy Division, Tokyo, Japan. FAU - Saito, Yutaka AU - Saito Y AD - National Cancer Center Hospital, Endoscopy Division, Tokyo, Japan. LA - eng PT - Journal Article DEP - 20190503 PL - Germany TA - Endosc Int Open JT - Endoscopy international open JID - 101639919 PMC - PMC6499619 COIS- Competing interests None EDAT- 2019/05/08 06:00 MHDA- 2019/05/08 06:01 PMCR- 2019/05/01 CRDT- 2019/05/08 06:00 PHST- 2018/06/29 00:00 [received] PHST- 2018/12/27 00:00 [accepted] PHST- 2019/05/08 06:00 [entrez] PHST- 2019/05/08 06:00 [pubmed] PHST- 2019/05/08 06:01 [medline] PHST- 2019/05/01 00:00 [pmc-release] AID - 10.1055/a-0848-8048 [doi] PST - ppublish SO - Endosc Int Open. 2019 May;7(5):E664-E671. doi: 10.1055/a-0848-8048. Epub 2019 May 3.